Insider Stock Trading History of Malik Rajesh


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Malik Rajesh since year 2005. The trader's CIK number is 1706853. At the time of this reporting, Malik Rajesh is the Ch. Medical Officer & SVP R&D of G1 Therapeutics, Inc. . (stock ticker symbol GTHX). See this page for all insider trading activities at G1 Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Malik Rajesh since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-09-17 GTHX G1 Therapeutics, Inc. Option Ex 3,776 4.17 15,745
2018-09-17 GTHX G1 Therapeutics, Inc. Sale 3,776 66.83 252,357
2018-08-15 GTHX G1 Therapeutics, Inc. Option Ex 3,776 4.17 15,745
2018-08-15 GTHX G1 Therapeutics, Inc. Sale 3,776 55.94 211,233
2018-07-16 GTHX G1 Therapeutics, Inc. Sale 3,776 42.30 159,743
2018-07-16 GTHX G1 Therapeutics, Inc. Option Ex 3,776 4.17 15,745
2018-06-15 GTHX G1 Therapeutics, Inc. Option Ex 3,776 4.17 15,745
2018-06-15 GTHX G1 Therapeutics, Inc. Sale 3,776 44.31 167,325
2018-06-08 GTHX G1 Therapeutics, Inc. Option Ex 4,200 .39 1,638
2018-05-15 GTHX G1 Therapeutics, Inc. Sale 3,776 46.48 175,504
2018-05-15 GTHX G1 Therapeutics, Inc. Option Ex 3,776 4.17 15,745
2018-04-16 GTHX G1 Therapeutics, Inc. Option Ex 3,776 4.17 15,745
2018-04-16 GTHX G1 Therapeutics, Inc. Sale 3,776 36.33 137,185
2018-03-15 GTHX G1 Therapeutics, Inc. Option Ex 3,776 2.28 8,609
2018-03-15 GTHX G1 Therapeutics, Inc. Sale 3,776 38.18 144,152
2018-03-08 GTHX G1 Therapeutics, Inc. Option Ex 4,200 .39 1,638
2018-02-15 GTHX G1 Therapeutics, Inc. Option Ex 3,776 .34 1,302
2018-02-15 GTHX G1 Therapeutics, Inc. Sale 3,776 20.00 75,520
2018-01-16 GTHX G1 Therapeutics, Inc. Sale 3,776 22.96 86,693
2018-01-16 GTHX G1 Therapeutics, Inc. Option Ex 3,776 .30 1,132

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Malik Rajesh (Ch. Medical Officer & SVP R&D of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.